Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kunimichi Niibe is active.

Publication


Featured researches published by Kunimichi Niibe.


Nature Protocols | 2012

Isolation of mouse mesenchymal stem cells on the basis of expression of Sca-1 and PDGFR-α.

Diarmaid D. Houlihan; Yo Mabuchi; Satoru Morikawa; Kunimichi Niibe; Daisuke Araki; Sadafumi Suzuki; Hideyuki Okano; Yumi Matsuzaki

Platelet-derived growth factor receptor α (PDGFR-α) and stem cell antigen 1 (Sca-1) have recently been identified as selective markers of mouse mesenchymal stem cells (MSCs). PDGFR-α+Sca-1+ (PαS) MSCs have augmented growth potential and robust tri-lineage differentiation compared with standard culture-selected MSCs. In addition, the selective isolation of PαS MSCs avoids cellular contamination that can complicate other methods. Here we describe in detail our protocol to isolate PαS MSCs using flow cytometry. In brief, the tibia and femora are isolated and crushed using a pestle and mortar. The crushed bones are then chopped and incubated for 1 h at 37 °C in 20 ml of DMEM containing 0.2% (wt/vol) collagenase. The cell suspension is filtered before red blood cell lysis and incubated with the following antibodies: allophycocyanin (APC)-conjugated PDGFR-α, FITC-conjugated Sca-1, phycoerythrin (PE)-conjugated CD45 and Ter119. Appropriate gates are constructed on a cell sorter to exclude dead cells and lineage (CD45+Ter-119+)-positive cells. Approximately 10,000 PαS MSCs may then be isolated per mouse. The total protocol takes ∼7 h to complete.


Stem cell reports | 2013

LNGFR+THY-1+VCAM-1hi+ Cells Reveal Functionally Distinct Subpopulations in Mesenchymal Stem Cells

Yo Mabuchi; Satoru Morikawa; Seiko Harada; Kunimichi Niibe; Sadafumi Suzuki; Francois Renault-Mihara; Diarmaid D. Houlihan; Chihiro Akazawa; Hideyuki Okano; Yumi Matsuzaki

Summary Human mesenchymal stem cells (hMSCs), which conventionally are isolated based on their adherence to plastic, are heterogeneous and have poor growth and differentiation, limiting our ability to investigate their intrinsic characteristics. We report an improved prospective clonal isolation technique and reveal that the combination of three cell-surface markers (LNGFR, THY-1, and VCAM-1) allows for the selection of highly enriched clonogenic cells (one out of three isolated cells). Clonal characterization of LNGFR+THY-1+ cells demonstrated cellular heterogeneity among the clones. Rapidly expanding clones (RECs) exhibited robust multilineage differentiation and self-renewal potency, whereas the other clones tended to acquire cellular senescence via P16INK4a and exhibited frequent genomic errors. Furthermore, RECs exhibited unique expression of VCAM-1 and higher cellular motility compared with the other clones. The combination marker LNGFR+THY-1+VCAM-1hi+ (LTV) can be used selectively to isolate the most potent and genetically stable MSCs.


PLOS ONE | 2011

Purified Mesenchymal Stem Cells Are an Efficient Source for iPS Cell Induction

Kunimichi Niibe; Yoshimi Kawamura; Daisuke Araki; Satoru Morikawa; Kyoko Miura; Sadafumi Suzuki; Shigeto Shimmura; Takehiko Sunabori; Yo Mabuchi; Yasuo Nagai; Taneaki Nakagawa; Hideyuki Okano; Yumi Matsuzaki

Background Induced pluripotent stem (iPS) cells are generated from mouse and human somatic cells by the forced expression of defined transcription factors. Although most somatic cells are capable of acquiring pluripotency with minimal gene transduction, the poor efficiency of cell reprogramming and the uneven quality of iPS cells are still important problems. In particular, the choice of cell type most suitable for inducing high-quality iPS cells remains unclear. Methodology/Principal Findings Here, we generated iPS cells from PDGFRα+ Sca-1+ (PαS) adult mouse mesenchymal stem cells (MSCs) and PDGFRα− Sca-1− osteo-progenitors (OP cells), and compared the induction efficiency and quality of individual iPS clones. MSCs had a higher reprogramming efficiency compared with OP cells and Tail Tip Fibroblasts (TTFs). The iPS cells induced from MSCs by Oct3/4, Sox2, and Klf4 appeared to be the closest equivalent to ES cells by DNA microarray gene profile and germline-transmission efficiency. Conclusions/Significance Our findings suggest that a purified source of undifferentiated cells from adult tissue can produce high-quality iPS cells. In this context, prospectively enriched MSCs are a promising candidate for the efficient generation of high-quality iPS cells.


Journal of Dental Research | 2016

Purified Human Dental Pulp Stem Cells Promote Osteogenic Regeneration

Takazumi Yasui; Yo Mabuchi; H. Toriumi; T. Ebine; Kunimichi Niibe; Diarmaid D. Houlihan; Satoru Morikawa; K. Onizawa; Hiromasa Kawana; Chihiro Akazawa; N. Suzuki; Taneaki Nakagawa; Hideyuki Okano; Yumi Matsuzaki

Human dental pulp stem/progenitor cells (hDPSCs) are attractive candidates for regenerative therapy because they can be easily expanded to generate colony-forming unit–fibroblasts (CFU-Fs) on plastic and the large cell numbers required for transplantation. However, isolation based on adherence to plastic inevitably changes the surface marker expression and biological properties of the cells. Consequently, little is currently known about the original phenotypes of tissue precursor cells that give rise to plastic-adherent CFU-Fs. To better understand the in vivo functions and translational therapeutic potential of hDPSCs and other stem cells, selective cell markers must be identified in the progenitor cells. Here, we identified a dental pulp tissue–specific cell population based on the expression profiles of 2 cell-surface markers LNGFR (CD271) and THY-1 (CD90). Prospectively isolated, dental pulp–derived LNGFRLow+THY-1High+ cells represent a highly enriched population of clonogenic cells—notably, the isolated cells exhibited long-term proliferation and multilineage differentiation potential in vitro. The cells also expressed known mesenchymal cell markers and promoted new bone formation to heal critical-size calvarial defects in vivo. These findings suggest that LNGFRLow+THY-1High+ dental pulp–derived cells provide an excellent source of material for bone regenerative strategies.


Biochemical and Biophysical Research Communications | 2009

Development of mesenchymal stem cells partially originate from the neural crest

Satoru Morikawa; Yo Mabuchi; Kunimichi Niibe; Sadafumi Suzuki; Narihito Nagoshi; Takehiko Sunabori; Shigeto Shimmura; Yasuo Nagai; Taneaki Nakagawa; Hideyuki Okano; Yumi Matsuzaki


Journal of Prosthodontic Research | 2015

Osteonecrosis of the jaw in patients with dental prostheses being treated with bisphosphonates or denosumab

Kunimichi Niibe; Takehito Ouchi; Ryotaro Iwasaki; Taneaki Nakagawa; Nobuyuki Horie


Inflammation and Regeneration | 2011

Mesp1 + early paraxial mesodermal cells supply initial bone marrow mesenchymal stem cells capable of differentiating into neural crest lineage cells

Kunimichi Niibe; Satoru Morikawa; Yo Mabuchi; Daisuke Araki; Taneaki Nakagawa; Hideyuki Okano; Yumi Matsuzaki


Inflammation and Regeneration | 2013

Primary evaluation of induced pluripotent stem cells using flow cytometry

Daisuke Araki; Yoshimi Kawamura; Kunimichi Niibe; Sadafumi Suzuki; Satoru Morikawa; Yo Mabuchi; Taneaki Nakagawa; Hideyuki Okano; Yumi Matsuzaki


Journal of Cell Biology | 2009

Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow

Satoru Morikawa; Yo Mabuchi; Yoshiaki Kubota; Yasuo Nagai; Kunimichi Niibe; Emi Hiratsu; Sadafumi Suzuki; Chikako Miyauchi-Hara; Narihito Nagoshi; Takehiko Sunabori; Shigeto Shimmura; Atsushi Miyawaki; Taneaki Nakagawa; Toshio Suda; Hideyuki Okano; Yumi Matsuzaki


Journal of oral surgery | 2007

A case of a large calcifying cystic odontogenic tumor associated with odontoma

Kazuhiko Hashimoto; Kaori Yago; Kunimichi Niibe; Taneaki Nakagawa; Soichiro Asanami; Yoichi Tanaka

Collaboration


Dive into the Kunimichi Niibe's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yo Mabuchi

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge